Statistics

Total Visits

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)16

Select a period of time:

Number of views in the range

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)11

Views

Views
October 20232
November 20235
December 20231
January 20241
February 20241
March 20241
April 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Spain2
 

Top cities views

Views
Ashburn5
Boardman2